Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 34
- Uncategorized
FDA Hammered by Lawmakers on Capitol Hill for Allowing Intoxicating Hemp Industry to Flourish
The US Food and Drug Administration (FDA) was dragged through the mud by lawmakers yesterday, who said its ‘bureaucratic red tape, inefficiencies, and weak oversight’ was responsible for the flood of intoxicating hemp substances across the country.
- Markets & Stocks
Argent Bio’s Stock Flies on German Approval, Jazz Hit by Tariff Barrage, & Kanabo Cautions ‘Financial Uncertainty’
Argent BioPharma [stock_market_widget type=”chart” template=”line” assets=”RGT.AX” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Argent BioPharma has managed to overcome the wider chaos on the stock markets this week, seeing its stock jump over 40% in the wake of two major announcements.
- Uncategorized
Tilray’s Stock Price Drops Over 20% as Q3 Financials Miss Estimates
Tilray’s stock price has tumbled some 24% since the start of the week as its Q3 2025 financial figures failed to meet analysts’ expectations.
- Companies
‘Unfinished Business’: Why the Man Behind Epidyolex Global Success Is Betting on Ananda Pharma
Ananda Pharma, now the leading force in pharmaceutical cannabis research in the UK, has announced that the former Chief Operating Officer of GW Pharmaceuticals and Jazz Pharmaceuticals will join its team.
- Uncategorized
Hundreds of Hemp Advocates ‘Flood’ Texas Hearing on Controversial Hemp Bans
Yesterday hearings on two bills which threaten to ‘dismantle’ Texas’s thriving hemp industry ran for a marathon of 18 hours, with the majority of participants testifying against the punitive measures.
- Events
PHCann International Announced as Headline Sponsor of Cannabis Europa London 2025
PHCANN International, a leading multinational pharmaceutical cannabis company, has been announced as the headline sponsor of Cannabis Europa, taking place in London on 24-25 June, 2025.
- Opinion
The Future of Pharmaceuticals: How Cannabinoids Are Redefining the Industry
In recent years, the pharmaceutical landscape has witnessed a seismic shift as cannabinoids transition from niche alternatives to mainstream medical solutions.
- Uncategorized
US Committee Hearing to Examine FDA’s ‘Failure’ to Regulate Intoxicating Hemp Substances
The US House Committee on Oversight and Government Reform is set to hold a hearing to examine the Food and Drug Administration’s (FDA) apparent ‘failure’ to prevent the flood of intoxicating hemp products across the country.
- Hemp Industry
Italian Government Uses ‘Emergency’ Powers to Push Through Hemp Flower Ban, Criminalising 22,000 People Overnight
The final nail in the coffin of Italy’s booming ‘cannabis light’ sector, appears to have been hammered into place by the government.
- Uncategorized
Trump Creates ‘Safe & Beautiful’ Task Force in DC Targeting ‘Failed’ Cannabis Legalization Policies
Central to the order is the creation of the oddly-named ‘DC Safe and Beautiful Task Force’, tasked with ‘preventing crime, punishing criminals, preserving order… and promoting the beautification’ in the state.
- Uncategorized
Organigram ‘Fast-Tracks’ Entrance Into the US and THC-Beverages Market Through $24m Acquisition
Just days after announcing a comprehensive rebrand as it shifts its focus to international markets, Organigram Global has acquired Hamilton-based Collective Project Limited (CPL) in a deal worth up to C$24m.
- Uncategorized
Welche Auswirkungen hat die teilweise Legalisierung von Cannabis in Deutschland nach einem Jahr?
Seit dem 01. April 2024 wurden Hunderte von Millionen Euro in den deutschen medizinischen Cannabissektor investiert, Hunderttausende von Strafverfahren wurden vermieden und Millionen von Bürgern haben zum ersten Mal freien und legalen Zugang zu Cannabis erhalten.
